论文信息 - Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis - 字舞流文

Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis

K. Michaud | S. Duvall | A. Reimold | L. Caplan | D. Collier | T. Mikuls | J. Curtis | D. Harrison | G. Joseph | B. Sauer | G. Cannon | C. Haroldsen